- Home
- UGRO vs JAGX Comparison
UGRO vs JAGX Comparison
Compare UGRO & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- JAGX
- Stock Information
- Founded
- UGRO 2014
- JAGX 2013
- Country
- UGRO United States
- JAGX United States
- Employees
- UGRO N/A
- JAGX N/A
- Industry
- UGRO Industrial Specialties
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- JAGX Health Care
- Exchange
- UGRO Nasdaq
- JAGX Nasdaq
- Market Cap
- UGRO 3.8M
- JAGX 3.4M
- IPO Year
- UGRO N/A
- JAGX N/A
- Fundamental
- Price
- UGRO $0.40
- JAGX $1.98
- Analyst Decision
- UGRO Strong Buy
- JAGX Strong Buy
- Analyst Count
- UGRO 1
- JAGX 1
- Target Price
- UGRO $3.00
- JAGX $60.00
- AVG Volume (30 Days)
- UGRO 488.3K
- JAGX 96.9K
- Earning Date
- UGRO 08-12-2025
- JAGX 08-12-2025
- Dividend Yield
- UGRO N/A
- JAGX N/A
- EPS Growth
- UGRO N/A
- JAGX N/A
- EPS
- UGRO N/A
- JAGX N/A
- Revenue
- UGRO $59,985,138.00
- JAGX $11,552,000.00
- Revenue This Year
- UGRO N/A
- JAGX $22.41
- Revenue Next Year
- UGRO $31.25
- JAGX $30.00
- P/E Ratio
- UGRO N/A
- JAGX N/A
- Revenue Growth
- UGRO N/A
- JAGX 13.93
- 52 Week Low
- UGRO $0.26
- JAGX $1.93
- 52 Week High
- UGRO $1.92
- JAGX $35.25
- Technical
- Relative Strength Index (RSI)
- UGRO 50.89
- JAGX 23.93
- Support Level
- UGRO $0.42
- JAGX $2.19
- Resistance Level
- UGRO $0.55
- JAGX $2.79
- Average True Range (ATR)
- UGRO 0.07
- JAGX 0.10
- MACD
- UGRO 0.00
- JAGX 0.04
- Stochastic Oscillator
- UGRO 37.73
- JAGX 8.60
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.